Annual Working Capital
-$10.56 M
-$12.80 M-571.35%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual working capital is -$10.56 million, with the most recent change of -$12.80 million (-571.35%) on December 31, 2023.
- During the last 3 years, SLS annual working capital has fallen by -$35.15 million (-142.96%).
- SLS annual working capital is now -142.48% below its all-time high of $24.87 million, reached on December 31, 2014.
Performance
SLS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$13.42 M
+$13.16 M+5122.57%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly working capital is $13.42 million, with the most recent change of +$13.16 million (+5122.57%) on September 30, 2024.
- Over the past year, SLS quarterly working capital has increased by +$23.98 million (+227.07%).
- SLS quarterly working capital is now -55.76% below its all-time high of $30.34 million, reached on June 30, 2021.
Performance
SLS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SLS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -571.4% | +227.1% |
| 3 y3 years | -143.0% | +521.4% |
| 5 y5 years | -7666.9% | +521.4% |
SLS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -158.5% | at low | -25.7% | +227.1% |
| 5 y | 5-year | -143.0% | at low | -55.8% | +227.1% |
| alltime | all time | -142.5% | +8.0% | -55.8% | +173.3% |
SELLAS Life Sciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.42 M(+5122.6%) |
| Jun 2024 | - | $257.00 K(-96.4%) |
| Mar 2024 | - | $7.06 M(-166.9%) |
| Dec 2023 | -$10.56 M(-571.4%) | -$10.56 M(+61.7%) |
| Sep 2023 | - | -$6.53 M(-402.4%) |
| Jun 2023 | - | $2.16 M(-79.5%) |
| Mar 2023 | - | $10.51 M(+369.0%) |
| Dec 2022 | $2.24 M(-87.6%) | $2.24 M(-77.7%) |
| Sep 2022 | - | $10.05 M(-39.3%) |
| Jun 2022 | - | $16.55 M(+131.2%) |
| Mar 2022 | - | $7.16 M(-60.4%) |
| Dec 2021 | $18.06 M(-26.5%) | $18.06 M(-23.6%) |
| Sep 2021 | - | $23.66 M(-22.0%) |
| Jun 2021 | - | $30.34 M(+19.2%) |
| Mar 2021 | - | $25.46 M(+3.5%) |
| Dec 2020 | $24.59 M(+733.0%) | $24.59 M(+380.8%) |
| Sep 2020 | - | $5.11 M(+465.7%) |
| Jun 2020 | - | $904.00 K(-82.5%) |
| Mar 2020 | - | $5.16 M(+74.6%) |
| Dec 2019 | $2.95 M(-2270.6%) | $2.95 M(-36.3%) |
| Sep 2019 | - | $4.64 M(-43.7%) |
| Jun 2019 | - | $8.24 M(-445.1%) |
| Mar 2019 | - | -$2.39 M(+1655.9%) |
| Dec 2018 | -$136.00 K(-98.8%) | -$136.00 K(-102.3%) |
| Sep 2018 | - | $5.81 M(-141.7%) |
| Jun 2018 | - | -$13.93 M(+9.9%) |
| Mar 2018 | - | -$12.68 M(+10.4%) |
| Dec 2017 | -$11.48 M(-1949.0%) | -$11.48 M(+729.0%) |
| Sep 2017 | - | -$1.39 M(-38.3%) |
| Jun 2017 | - | -$2.25 M(-138.9%) |
| Mar 2017 | - | $5.78 M(+830.3%) |
| Dec 2016 | $621.00 K(-118.0%) | $621.00 K(-67.7%) |
| Sep 2016 | - | $1.92 M(-199.0%) |
| Jun 2016 | - | -$1.94 M(-54.6%) |
| Mar 2016 | - | -$4.27 M(+23.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | -$3.45 M(-113.9%) | -$3.45 M(-120.2%) |
| Sep 2015 | - | $17.10 M(+31.4%) |
| Jun 2015 | - | $13.01 M(-44.3%) |
| Mar 2015 | - | $23.36 M(-6.1%) |
| Dec 2014 | $24.87 M(-375.7%) | $24.87 M(-911.3%) |
| Sep 2014 | - | -$3.06 M(-129.8%) |
| Jun 2014 | - | $10.27 M(-64.5%) |
| Mar 2014 | - | $28.94 M(-420.9%) |
| Dec 2013 | -$9.02 M(-144.6%) | -$9.02 M(-144.5%) |
| Sep 2013 | - | $20.27 M(+1028.7%) |
| Jun 2013 | - | $1.80 M(+59.9%) |
| Mar 2013 | - | $1.12 M(-94.4%) |
| Dec 2012 | $20.20 M(+3222.7%) | $20.20 M(+222.3%) |
| Sep 2012 | - | $6.27 M(-41.8%) |
| Jun 2012 | - | $10.77 M(-158.8%) |
| Mar 2012 | - | -$18.30 M(-3109.9%) |
| Dec 2011 | $608.00 K(-69.8%) | $608.00 K(-111.5%) |
| Sep 2011 | - | -$5.27 M(-484.1%) |
| Jun 2011 | - | $1.37 M(-50.6%) |
| Mar 2011 | - | $2.78 M(+38.1%) |
| Dec 2010 | $2.02 M(+512.5%) | $2.02 M(-30.3%) |
| Sep 2010 | - | $2.89 M(-52.0%) |
| Jun 2010 | - | $6.03 M(-7.5%) |
| Mar 2010 | - | $6.51 M(+1880.2%) |
| Dec 2009 | $329.00 K(-96.1%) | $329.00 K(-93.8%) |
| Sep 2009 | - | $5.33 M(+88.6%) |
| Jun 2009 | - | $2.83 M(-53.4%) |
| Mar 2009 | - | $6.07 M(-28.9%) |
| Dec 2008 | $8.54 M(-18.0%) | $8.54 M(-27.8%) |
| Sep 2008 | - | $11.82 M(-15.0%) |
| Jun 2008 | - | $13.91 M(+65.5%) |
| Mar 2008 | - | $8.40 M(-19.3%) |
| Dec 2007 | $10.41 M(>+9900.0%) | $10.41 M(-16.9%) |
| Sep 2007 | - | $12.53 M(>+9900.0%) |
| Dec 2006 | $2000.00 | $2000.00 |
FAQ
- What is SELLAS Life Sciences annual working capital?
- What is the all time high annual working capital for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual working capital year-on-year change?
- What is SELLAS Life Sciences quarterly working capital?
- What is the all time high quarterly working capital for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly working capital year-on-year change?
What is SELLAS Life Sciences annual working capital?
The current annual working capital of SLS is -$10.56 M
What is the all time high annual working capital for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual working capital is $24.87 M
What is SELLAS Life Sciences annual working capital year-on-year change?
Over the past year, SLS annual working capital has changed by -$12.80 M (-571.35%)
What is SELLAS Life Sciences quarterly working capital?
The current quarterly working capital of SLS is $13.42 M
What is the all time high quarterly working capital for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly working capital is $30.34 M
What is SELLAS Life Sciences quarterly working capital year-on-year change?
Over the past year, SLS quarterly working capital has changed by +$23.98 M (+227.07%)